Daiichi Sankyo sells 11.28% stake in Zenotech Laboratories to Sun Pharma

Daiichi Sankyo sold 68,86,500 shares of Zenotech Laboratories to Sun Pharma which represents 11.28% of equity share capital of Zenotech.

Post acquisition Sun Pharma’s holding in the company increased from 3 ,51,28,078 to 4,20,14,578 equity shares which represents 68.84% of Total Share Capital of Zenotech.